John M. Kane Receives 2026 SIRS Lifetime Achievement Award for Transformative Schizophrenia Research
核心洞察
John M. Kane, MD, co-director of the Institute of Behavioral Science at the Feinstein Institutes, was awarded the 2026 Lifetime Achievement Award from the Schizophrenia International Research Society (搜索).
The award was presented during the SIRS Annual Conference in Florence, Italy, recognizing his decades-long contributions to schizophrenia (搜索) understanding, treatment, and global patient outcomes.
Dr. Kane led the NIH-funded RAISE program that developed the NAVIGATE model of coordinated specialty care for first-episode psychosis patients and conducted groundbreaking research with clozapine for treatment-resistant schizophrenia (搜索).
John M. Kane, MD, co-director of the Institute of Behavioral Science at Northwell Health's Feinstein Institutes for Medical Research (搜索), has been awarded the 2026 Lifetime Achievement Award from the Schizophrenia International Research Society (搜索) (SIRS). The honor, considered one of the highest in the field of schizophrenia (搜索) research, was presented during the SIRS Annual Conference in Florence, Italy, in March 2026.
The SIRS Lifetime Achievement Award recognizes individuals who have made sustained and exceptional contributions to scientific understanding, clinical practice, and global impact over their careers. Dr. Kane's selection reflects his decades-long commitment to transforming the understanding, treatment, and outcomes for individuals living with schizophrenia (搜索) worldwide.
"I am very honored to receive this award," said Dr. Kane. "It is extremely gratifying to garner this level of peer recognition for work that has been inspired by patients and families, facilitated by mentors, colleagues and mentees and always a personal privilege."
A Career Defined by Pioneering Research
Dr. Kane's research portfolio is extensive and influential. He has served as principal investigator on 24 U.S. National Institutes of Health (NIH) grants and has authored over 950 peer-reviewed papers published in leading journals. His work has focused on the psychobiology and treatment of schizophrenia (搜索), recovery-oriented care, improving quality and cost-effectiveness of care, and leveraging digital technology for enhanced patient outcomes.
Among his landmark achievements is leading the NIH-funded Recovery After an Initial Schizophrenia (搜索) Episode (RAISE) program, which developed the NAVIGATE model of coordinated specialty care (CSC) for first-episode psychosis (FEP) patients. This model has helped reshape early intervention approaches for individuals experiencing their first psychotic episode.
Dr. Kane is also renowned for his groundbreaking research with clozapine for treatment-resistant schizophrenia (搜索), as well as his continuous focus on the therapeutic and adverse effects of psychotropic drugs, thereby informing benefit-to-risk considerations in clinical practice.
Leadership and Academic Contributions
Beyond his research, Dr. Kane holds the title of professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Previously, he served as chair of Psychiatry for 34 years at Northwell's Zucker Hillside Hospital in Glen Oaks and as senior vice president for Behavioral Health Services at Northwell.
His leadership in the psychiatric community is further evidenced by his service as president of the American Society of Clinical Psychopharmacology, the Psychiatry Research Society, and the Schizophrenia International Research Society (搜索), among other prestigious appointments.
"Dr. John Kane's dedication and pioneering spirit have not only shaped the landscape of schizophrenia (搜索) research, but have also directly improved the lives of countless patients and families globally," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. "His well-deserved acknowledgement with the SIRS Lifetime Achievement Award recognizes his lifelong commitment to understanding mental health and behavioral health."
The Feinstein Institutes for Medical Research (搜索), home to the research institutes of Northwell Health, encompasses more than 50 research labs, 3,000 clinical research studies, and 5,000 researchers and staff across its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research.